Global Head and Neck Cancer Treatment Market 2023-2027

Description

List of Tables

The head and neck cancer treatment market is forecasted to grow by USD 5077.38 mn during 2022-2027, accelerating at a CAGR of 11.27% during the forecast period. The report on the head and neck cancer treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of head and neck cancers, growing geriatric population, and increasing number of cancer-related initiatives.

Technavio's head and neck cancer treatment market is segmented as below:

By Route Of Administration

Injectable
Oral

By Therapy

Immunotherapy
Targeted therapy
Chemotherapy

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the technological advancements in diagnosis and treatment as one of the prime reasons driving the head and neck cancer treatment market growth during the next few years. Also, growing demand for minimally invasive procedures and growing trend of oncology-related medical tourism will lead to sizable demand in the market.

The report on the head and neck cancer treatment market covers the following areas:

Head and neck cancer treatment market sizing
Head and neck cancer treatment market forecast
Head and neck cancer treatment market analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading head and neck cancer treatment market vendors that include Amgen Inc., AstraZeneca Plc, Ayala Pharmaceuticals Inc., Bristol Myers Squibb Co., Debiopharm International SA, Eli Lilly and Co., Incyte Corp., Merck and Co. Inc., Novartis AG, Pfizer Inc., and Sanofi. Also, the head and neck cancer treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR76034

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 06: Executive Summary - Chart on Market Segmentation by Therapy
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global head and neck cancer treatment market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global head and neck cancer treatment market 2017 - 2021 ($ million)
4.2 Route of Administration Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ million)
4.3 Therapy Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Route of Administration

6.1 Market segments
Exhibit 30: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibit 31: Data Table on Route of Administration - Market share 2022-2027 (%)
6.2 Comparison by Route of Administration
Exhibit 32: Chart on Comparison by Route of Administration
Exhibit 33: Data Table on Comparison by Route of Administration
6.3 Injectable - Market size and forecast 2022-2027
Exhibit 34: Chart on Injectable - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Injectable - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Injectable - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Injectable - Year-over-year growth 2022-2027 (%)
6.4 Oral - Market size and forecast 2022-2027
Exhibit 38: Chart on Oral - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Oral - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Oral - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Route of Administration
Exhibit 42: Market opportunity by Route of Administration ($ million)
Exhibit 43: Data Table on Market opportunity by Route of Administration ($ million)

7 Market Segmentation by Therapy

7.1 Market segments
Exhibit 44: Chart on Therapy - Market share 2022-2027 (%)
Exhibit 45: Data Table on Therapy - Market share 2022-2027 (%)
7.2 Comparison by Therapy
Exhibit 46: Chart on Comparison by Therapy
Exhibit 47: Data Table on Comparison by Therapy
7.3 Immunotherapy - Market size and forecast 2022-2027
Exhibit 48: Chart on Immunotherapy - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Immunotherapy - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Immunotherapy - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Immunotherapy - Year-over-year growth 2022-2027 (%)
7.4 Targeted therapy - Market size and forecast 2022-2027
Exhibit 52: Chart on Targeted therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Targeted therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Targeted therapy - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Targeted therapy - Year-over-year growth 2022-2027 (%)
7.5 Chemotherapy - Market size and forecast 2022-2027
Exhibit 56: Chart on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Chemotherapy - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Chemotherapy - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Therapy
Exhibit 60: Market opportunity by Therapy ($ million)
Exhibit 61: Data Table on Market opportunity by Therapy ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 63: Chart on Market share by geography 2022-2027 (%)
Exhibit 64: Data Table on Market share by geography 2022-2027 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
Exhibit 87: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 UK - Market size and forecast 2022-2027
Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity by geography
Exhibit 103: Market opportunity by geography ($ million)
Exhibit 104: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Amgen Inc.
Exhibit 111: Amgen Inc. - Overview
Exhibit 112: Amgen Inc. - Product / Service
Exhibit 113: Amgen Inc. - Key offerings
12.4 AstraZeneca Plc
Exhibit 114: AstraZeneca Plc - Overview
Exhibit 115: AstraZeneca Plc - Product / Service
Exhibit 116: AstraZeneca Plc - Key news
Exhibit 117: AstraZeneca Plc - Key offerings
12.5 Ayala Pharmaceuticals Inc.
Exhibit 118: Ayala Pharmaceuticals Inc. - Overview
Exhibit 119: Ayala Pharmaceuticals Inc. - Product / Service
Exhibit 120: Ayala Pharmaceuticals Inc. - Key offerings
12.6 Bristol Myers Squibb Co.
Exhibit 121: Bristol Myers Squibb Co. - Overview
Exhibit 122: Bristol Myers Squibb Co. - Product / Service
Exhibit 123: Bristol Myers Squibb Co. - Key news
Exhibit 124: Bristol Myers Squibb Co. - Key offerings
12.7 Debiopharm International SA
Exhibit 125: Debiopharm International SA - Overview
Exhibit 126: Debiopharm International SA - Product / Service
Exhibit 127: Debiopharm International SA - Key news
Exhibit 128: Debiopharm International SA - Key offerings
12.8 Eli Lilly and Co.
Exhibit 129: Eli Lilly and Co. - Overview
Exhibit 130: Eli Lilly and Co. - Product / Service
Exhibit 131: Eli Lilly and Co. - Key news
Exhibit 132: Eli Lilly and Co. - Key offerings
12.9 Incyte Corp.
Exhibit 133: Incyte Corp. - Overview
Exhibit 134: Incyte Corp. - Product / Service
Exhibit 135: Incyte Corp. - Key offerings
12.10 Merck and Co. Inc.
Exhibit 136: Merck and Co. Inc. - Overview
Exhibit 137: Merck and Co. Inc. - Business segments
Exhibit 138: Merck and Co. Inc. - Key news
Exhibit 139: Merck and Co. Inc. - Key offerings
Exhibit 140: Merck and Co. Inc. - Segment focus
12.11 Novartis AG
Exhibit 141: Novartis AG - Overview
Exhibit 142: Novartis AG - Business segments
Exhibit 143: Novartis AG - Key offerings
Exhibit 144: Novartis AG - Segment focus
12.12 Pfizer Inc.
Exhibit 145: Pfizer Inc. - Overview
Exhibit 146: Pfizer Inc. - Product / Service
Exhibit 147: Pfizer Inc. - Key news
Exhibit 148: Pfizer Inc. - Key offerings
12.13 Sanofi
Exhibit 149: Sanofi - Overview
Exhibit 150: Sanofi - Business segments
Exhibit 151: Sanofi - Key news
Exhibit 152: Sanofi - Key offerings
Exhibit 153: Sanofi - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 154: Inclusions checklist
Exhibit 155: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 156: Currency conversion rates for US$
13.4 Research methodology
Exhibit 157: Research methodology
Exhibit 158: Validation techniques employed for market sizing
Exhibit 159: Information sources
13.5 List of abbreviations
Exhibit 160: List of abbreviations